-

Dr. Keri Bergin Joins Reproductive Medicine Associates to Expand Fertility Care in Los Angeles and Burbank

Board-Certified Reproductive Endocrinologist To See Patients In Los Angeles And Burbank Clinics

LOS ANGELES--(BUSINESS WIRE)--Reproductive Medicine Associates (RMA), one of the nation's leading reproductive service providers and a pioneer in IVF research, today announced that Keri Bergin, MD, a board-certified reproductive endocrinologist with nearly 15 years of hands-on fertility care experience, has joined its Southern California physician team. Dr. Bergin will care for patients at RMA's Los Angeles and Burbank clinics, expanding access to advanced fertility treatment and personalized family-building support for individuals and couples across the region.

“I feel incredibly lucky to work in a field that touches so many lives,” said Dr. Keri Bergin. “Whether navigating infertility or planning for the future, I'm here to support my patients through both the challenges and the celebrations."

Dr. Bergin’s journey into medicine began at the front desk of a New York City fertility clinic. That early experience led her to become an IVF coordinator, earn her medical degree at Thomas Jefferson University, complete her OB/GYN residency at Albany Medical Center, and pursue fellowship training in Reproductive Endocrinology and Infertility at RMA of New York/Mount Sinai Hospital. Dr. Bergin has published fertility research in leading journals, including Fertility & Sterility, JMIG and IJGO and presented nationally on advances in patient care.

Dr. Bergin is based in Los Angeles with her wife. She is committed to supporting members of the LGBTQ+ community preserve their fertility and achieve their family building dreams. Her care approach combines clinical excellence with a deep understanding and compassion for the personal and emotional journey of fertility treatment.

“Dr. Bergin is an exceptional addition to RMA’s clinical team in Southern California,” said Dr. Scott Morin, Physician Partner and West Coast Medical Director for RMA. “Her extensive experience in reproductive medicine combined with her genuine commitment to helping patients through their fertility journey aligns perfectly with our mission. She will make an immediate and meaningful impact on our patients and community.”

At RMA Los Angeles and RMA Burbank, Dr. Bergin will offer comprehensive fertility services, including in vitro fertilization (IVF), intrauterine insemination (IUI), egg and embryo freezing, preimplantation genetic testing (PGT), donor egg and sperm programs, gestational surrogacy coordination and fertility preservation for individuals facing medical treatments or life circumstances that may affect their future family-building plans.

Dr. Bergin is now accepting new patients at RMA Los Angeles and RMA Burbank. Appointments can be made by calling the office at 866-762-3140 or visiting https://rmanetwork.com/contact-us/.

About RMA

Reproductive Medicine Associates (RMA) has been helping build families through the most advanced treatment options and patient-centered fertility care for 25 years. RMA is a leader in IVF research, having pioneered Single Embryo Transfer (SET) and Pre-Implantation Genetic Testing (PGT-A), dramatically increasing successful outcomes and safety for mothers and babies alike. With access to practices nationwide, RMA has helped welcome over 60,000 babies into loving families. Learn more at rmanetwork.com.

Contacts

Media Contact
Cindi Goodsell
cgoodsell@stantonprm.com
510-409-3646

Reproductive Medicine Associates


Release Versions

Contacts

Media Contact
Cindi Goodsell
cgoodsell@stantonprm.com
510-409-3646

More News From Reproductive Medicine Associates

Boston IVF Partners with Gaia and PatientFi to Make Fertility Treatment More Accessible

BOSTON--(BUSINESS WIRE)--Boston IVF, one of the nation’s leading reproductive service providers and a pioneer in IVF research, today announced new partnerships with Gaia, the first provider of value-based family building, and PatientFi, a modern, patient-friendly financing platform offering zero-interest plan options*, flexible monthly terms up to 84 months**, and financing that covers the entire fertility journey from treatments, and medications to labs, testing, and out-of-pocket expenses. Th...

IVI RMA North America Enters New York City Market through Partnership with Island Reproductive Services

BASKING RIDGE, N.J.--(BUSINESS WIRE)--IVI RMA North America, a leader in fertility care and assisted reproduction, today announced it has finalized a new partnership with Island Reproductive Services (“IRS” or “the Company”), the only reproductive medicine provider on Staten Island to have a fertility lab and offer comprehensive fertility treatment to its patients. The company’s partners, Dr. Eric Knochenhauer and Dr. Michael Traub, will retain an equity stake in the business and continue servi...

The 2025 World Fertility Awards Names First Legacy Award After IVI RMA Global Founder and Chairman, Prof. Antonio Pellicer

MADRID--(BUSINESS WIRE)--The inaugural World Fertility Awards (WFAs), presented by global media platform Pregnantish, has named its 2025 Legacy Award after Professor Antonio Pellicer, Co-Founder and Executive Chair of the Board of Directors for IVI RMA Global. Prof. Pellicer is a renowned IVF pioneer and one of the most influential figures in reproductive medicine. Recognizing his impact on the field, the eponymous 2025 Prof. Antonio Pellicer Legacy Award will be given to an individual whose sc...
Back to Newsroom